81% rise in Victoza sales drives Novo Nordisk earnings

Article Date: 27/04/2012 10:33
81% rise in Victoza sales drives Novo Nordisk earnings

Vacancy Search

Quick job search

Advanced Search

Latest News

Merck Serono and Intrexon sign $941m CAR-T deal

Merck Serono and Intrexon sign $941m CAR-T deal

Speedy US review for Amgen's Kyprolis

Speedy US review for Amgen's Kyprolis

Novartis in $250m cancer immunotherapy pact with Aduro

Novartis in $250m cancer immunotherapy pact with Aduro

EU to review Biogen/AbbVie's once-monthly MS jab

EU to review Biogen/AbbVie's once-monthly MS jab

UK biotech consortium wins £6.2m AMSCI grant

UK biotech consortium wins £6.2m AMSCI grant

Behind the management smokescreen, Genfit study is still a fail

Management of the French company Genfit should be congratulated for the ingenuity with which they sliced and diced the data from the long-awaited Golden study of GFT505 in NASH, but the...

Auspex not the most auspicious start to Teva's M&A push

Teva’s $3.5bn takeout of Auspex Pharmaceuticals is not the transformational deal many of its investors want, but it brings on board the sort of product that the Israel-based group has been...

Stryker and Osiris step into the bony void

Biological grafts for orthopaedic applications have had a troubled history, with products from both Wright Medical and Medtronic getting caught out by safety concerns. But Osiris...

INTERVIEW: Accenture's David Logue talks digital pharma

INTERVIEW: Accenture's David Logue talks digital pharma

Five new drugs put forward for approval in Europe

Five new drugs put forward for approval in Europe
more news